Drugs Information: Tasimelteon
Basic Information
|
||
| ID | DDInter1747 | |
| Drug Type | small molecule | |
| Molecular Formula | C15H19No2 | |
| Molecular Weight | 245.322 | |
| Description | Tasimelteon is a melatonin receptor agonist used to treat Non- 24-Hour Sleep-Wake Disorder. | |
| ATC Classification | N05CH03 | |
| IUPAC Name | N-{[(1R,2R)-2-(2,3-Dihydro-1-Benzofuran-4-Yl)Cyclopropyl]Methyl}Propanamide | |
| InChI | Inchi=1S/C15H19No2/C1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/H3-5,10,13H,2,6-9H2,1H3,(H,16,17)/T10-,13+/M0/S1 | |
| InChI Key | PTOIAAWZLUQTIO-GXFFZTMASA-N | |
| Canonical SMILES | CCC(=O)NC[C@@H]1C[C@H]1C1=CC=CC2=C1CCO2 | |
| Useful Links | DrugBank ChEMBL PubChem | |
Interactions with Tasimelteon
| Severity level | ID | Name | Mechanism | Detail |
|---|